Keywords: liposome, segix, boost, elan, revenues, dublin, ireland-based
Liposome and Segix boost Elan revenues
Article | 21 July 2000
Dublin, Ireland-based drugmaker and drug delivery specialist Elan Corpreported an increase of 35% in net income, at $17.9 million for the second ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
